• Takeda Sees Lower Annual Profit, Generics to Erode Cancer Drug Sales

    10 monthes ago - By Medscape

    Japan's Takeda Pharmaceutical Co Ltd on Monday forecast a 17 percent drop in operating profit for the year through March 2019 as blood cancer drug Velcade looks set to face generic competition in the United States.
    Reuters Health Information
    Read more ...